Benzamides

"Benzamides" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure, which enables searching at various levels of specificity.

MeSH information

Definition | Details | More General Concepts | Related Concepts | More Specific Concepts

BENZOIC ACID amides.

Descriptor ID	D001549
MeSH Number(s)	D02.065.277 D02.241.223.100.100 D02.455.426.559.389.127.085
Concept/Terms	Benzamides Benzamides

Below are MeSH descriptors whose meaning is more general than "Benzamides".

Chemicals and Drugs [D]
Organic Chemicals [D02]
Amides [D02.065]
Benzamides [D02.065.277]
Carboxylic Acids [D02.241]
Acids, Carbocyclic [D02.241.223]
Benzoates [D02.241.223.100]
Benzamides [D02.241.223.100.100]
Hydrocarbons [D02.455]
Hydrocarbons, Cyclic [D02.455.426]
Hydrocarbons, Aromatic [D02.455.426.559]
Benzene Derivatives [D02.455.426.559.389]
Benzoates [D02.455.426.559.389.127]
Benzamides [D02.455.426.559.389.127.085]

Below are MeSH descriptors whose meaning is related to "Benzamides".

Below are MeSH descriptors whose meaning is more specific than "Benzamides".

publications

Timeline | Most Recent

This graph shows the total number of publications written about "Benzamides" by people in this website by year, and whether "Benzamides" was a major or minor topic of these publications.

Bar chart showing 57 publications over 19 distinct years, with a maximum of 6 publications in 2016

To see the data from this visualization as text, click here.

Year	Major Topic	Minor Topic	Total
2000	0	1	1
2005	0	1	1
2007	0	1	1
2008	0	3	3
2009	2	3	5
2010	0	5	5
2011	2	3	5
2012	3	1	4
2013	3	2	5
2014	2	2	4
2015	2	0	2
2016	5	1	6
2017	1	1	2
2018	2	0	2
2019	2	0	2
2020	1	1	2
2021	0	1	1
2022	0	2	2
2025	0	4	4

Below are the most recent publications written about "Benzamides" by people in Profiles.

Candelieri-Surette D, Cheranda N, Lee J, Teerlink CC, Pimentel C, Lynch JA, Berlowitz D, Schoen MW. The Impact of Race on Survival and Treatment in Veterans Treated for Metastatic Castration-Resistant Prostate Cancer. J Natl Compr Canc Netw. 2025 Dec; 23(12):507-515.

View in: PubMed
Honwad HH, Najibi M, Shen J, Watts S, Fu AM, Koscso B, Bogunovic M, Irazoqui JE. TFEB-mediated proinflammatory response in murine macrophages induced by acute Alpha7 nicotinic receptor activation. J Leukoc Biol. 2025 Jun 04; 117(6).

View in: PubMed
Gramatica A, Miller IG, Ward AR, Khan F, Kemmer TJ, Weiler J, Huynh TT, Zumbo P, Kurland AP, Leyre L, Ren Y, Klevorn T, Copertino DC, Chukwukere U, Levinger C, Dilling TR, Linden N, Board NL, Falling Iversen E, Terry S, Mota TM, Bedir S, Clayton KL, Bosque A, MacLaren Ehui L, Kovacs C, Betel D, Johnson JR, Paiardini M, Danesh A, Jones RB. EZH2 inhibition mitigates HIV immune evasion, reduces reservoir formation, and promotes skewing of CD8+ T cells toward less-exhausted phenotypes. Cell Rep. 2025 May 27; 44(5):115652.

View in: PubMed
Oka T, Smith SS, Oliver-Garcia VS, Lee T, Son HG, Mortaja M, Azin M, Garza-Mayers AC, Huang JT, Nazarian RM, Horn TD, Demehri S. Epigenomic regulation of stemness contributes to the low immunogenicity of the most mutated human cancer. Cell Rep. 2025 May 27; 44(5):115561.

View in: PubMed
Nicolas SE, Bear MD, Kanaan AO, Coman OA, Dima L. Roflumilast 0.3% Cream: a Phosphodiesterase 4 Inhibitor for the Treatment of Chronic Plaque Psoriasis. Am J Ther. 2023 Nov-Dec 01; 30(6):e535-e542.

View in: PubMed
Cash-Goldwasser S, Labuda SM, McCormick DW, Rao AK, McCollum AM, Petersen BW, Chodosh J, Brown CM, Chan-Colenbrander SY, Dugdale CM, Fischer M, Forrester A, Griffith J, Harold R, Furness BW, Huang V, Kaufman AR, Kitchell E, Lee R, Lehnertz N, Lynfield R, Marsh KJ, Madoff LC, Nicolasora N, Patel D, Pineda R, Powrzanas T, Roberts A, Seville MT, Shah A, Wong JM, Ritter JM, Schrodt CA, Raizes E, Morris SB, Gold JAW. Ocular Monkeypox - United States, July-September 2022. MMWR Morb Mortal Wkly Rep. 2022 Oct 21; 71(42):1343-1347.

View in: PubMed
Shayan M, Eslami F, Amanlou A, Solaimanian S, Rahimi N, Rashidian A, Ejtemaei-Mehr S, Ghasemi M, Dehpour AR. Neuroprotective effects of Lasmiditan and Sumatriptan in an experimental model of post-stroke seizure in mice: Higher effects with concurrent opioid receptors or KATP channels inhibitors. Toxicol Appl Pharmacol. 2022 11 01; 454:116254.

View in: PubMed
Santoni M, Massari F, Rizzo A, Mollica V, Cimadamore A, Montironi R, Battelli N. Apalutamide or enzalutamide in castration-sensitive prostate cancer: a number needed to treat analysis. Tumori. 2023 Apr; 109(2):157-163.

View in: PubMed
Rizzo A, Oderda M, Mollica V, Merler S, Morelli F, Fragomeno B, Taveri E, Sorgentoni G, Santoni M, Massari F. A meta-analysis on overall survival and safety outcomes in patients with nonmetastatic castration-resistant prostate cancer treated with novel hormonal agents. Anticancer Drugs. 2022 01 01; 33(1):e43-e51.

View in: PubMed
Chapman BP, Lai JT, Krotulski AJ, Fogarty MF, Griswold MK, Logan BK, Babu KM. A Case of Unintentional Opioid (U-47700) Overdose in a Young Adult After Counterfeit Xanax Use. Pediatr Emerg Care. 2021 Sep 01; 37(9):e579-e580.

View in: PubMed

People

Explore

Similar Concepts

Top Journals